Study to compare booster vaccination with Pediacel [Hib-DTaP-poliovirus vaccine] to Infanrix Hexa [Hib-DTaP-hepatitis B-poliovirus vaccine] when both are co-administered with Prevenar [pneumococcal 7-valent CRM197 vaccine conjugate].

Trial Profile

Study to compare booster vaccination with Pediacel [Hib-DTaP-poliovirus vaccine] to Infanrix Hexa [Hib-DTaP-hepatitis B-poliovirus vaccine] when both are co-administered with Prevenar [pneumococcal 7-valent CRM197 vaccine conjugate].

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jan 2015

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hepatitis B vaccine recombinant; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa); Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 09 Jun 2012 Results published in Vaccine.
    • 26 Jan 2010 Actual patient number (847) added as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top